Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AKQ5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 101 | 105 | PF00656 | 0.619 |
CLV_C14_Caspase3-7 | 56 | 60 | PF00656 | 0.544 |
CLV_C14_Caspase3-7 | 62 | 66 | PF00656 | 0.463 |
CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.608 |
CLV_NRD_NRD_1 | 280 | 282 | PF00675 | 0.665 |
CLV_NRD_NRD_1 | 283 | 285 | PF00675 | 0.662 |
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.507 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.633 |
CLV_PCSK_KEX2_1 | 280 | 282 | PF00082 | 0.643 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.609 |
CLV_PCSK_SKI1_1 | 259 | 263 | PF00082 | 0.663 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.716 |
DOC_MAPK_MEF2A_6 | 76 | 85 | PF00069 | 0.567 |
DOC_PP1_RVXF_1 | 82 | 88 | PF00149 | 0.426 |
DOC_PP2B_LxvP_1 | 20 | 23 | PF13499 | 0.418 |
DOC_PP4_FxxP_1 | 55 | 58 | PF00568 | 0.558 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.675 |
DOC_WW_Pin1_4 | 110 | 115 | PF00397 | 0.570 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.575 |
DOC_WW_Pin1_4 | 263 | 268 | PF00397 | 0.648 |
LIG_14-3-3_CanoR_1 | 129 | 137 | PF00244 | 0.550 |
LIG_14-3-3_CanoR_1 | 212 | 217 | PF00244 | 0.624 |
LIG_14-3-3_CanoR_1 | 84 | 92 | PF00244 | 0.439 |
LIG_FHA_1 | 120 | 126 | PF00498 | 0.616 |
LIG_FHA_1 | 183 | 189 | PF00498 | 0.674 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.491 |
LIG_FHA_1 | 52 | 58 | PF00498 | 0.435 |
LIG_FHA_2 | 2 | 8 | PF00498 | 0.653 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.495 |
LIG_LIR_Apic_2 | 2 | 8 | PF02991 | 0.653 |
LIG_LIR_Apic_2 | 215 | 219 | PF02991 | 0.718 |
LIG_LIR_Apic_2 | 54 | 58 | PF02991 | 0.560 |
LIG_LIR_Gen_1 | 15 | 23 | PF02991 | 0.425 |
LIG_LIR_Gen_1 | 182 | 190 | PF02991 | 0.731 |
LIG_LIR_Gen_1 | 89 | 100 | PF02991 | 0.485 |
LIG_LIR_Nem_3 | 15 | 20 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 177 | 181 | PF02991 | 0.608 |
LIG_LIR_Nem_3 | 182 | 186 | PF02991 | 0.615 |
LIG_LIR_Nem_3 | 264 | 268 | PF02991 | 0.709 |
LIG_LIR_Nem_3 | 51 | 55 | PF02991 | 0.569 |
LIG_LIR_Nem_3 | 89 | 95 | PF02991 | 0.489 |
LIG_MYND_1 | 135 | 139 | PF01753 | 0.605 |
LIG_PDZ_Class_3 | 307 | 312 | PF00595 | 0.789 |
LIG_SH2_CRK | 17 | 21 | PF00017 | 0.440 |
LIG_SH2_CRK | 265 | 269 | PF00017 | 0.725 |
LIG_SH2_NCK_1 | 265 | 269 | PF00017 | 0.729 |
LIG_SH2_STAT5 | 216 | 219 | PF00017 | 0.598 |
LIG_SH3_2 | 77 | 82 | PF14604 | 0.584 |
LIG_SH3_3 | 187 | 193 | PF00018 | 0.701 |
LIG_SH3_3 | 74 | 80 | PF00018 | 0.593 |
LIG_SUMO_SIM_par_1 | 121 | 127 | PF11976 | 0.633 |
LIG_SUMO_SIM_par_1 | 18 | 24 | PF11976 | 0.476 |
LIG_TRAF2_1 | 158 | 161 | PF00917 | 0.673 |
LIG_TRAF2_1 | 307 | 310 | PF00917 | 0.749 |
LIG_TRFH_1 | 186 | 190 | PF08558 | 0.648 |
LIG_WRC_WIRS_1 | 183 | 188 | PF05994 | 0.733 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.578 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.556 |
MOD_CK1_1 | 182 | 188 | PF00069 | 0.638 |
MOD_CK1_1 | 21 | 27 | PF00069 | 0.564 |
MOD_CK1_1 | 226 | 232 | PF00069 | 0.635 |
MOD_CK2_1 | 1 | 7 | PF00069 | 0.697 |
MOD_Cter_Amidation | 278 | 281 | PF01082 | 0.640 |
MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.481 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.650 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.505 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.468 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.716 |
MOD_GSK3_1 | 263 | 270 | PF00069 | 0.587 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.549 |
MOD_N-GLC_1 | 273 | 278 | PF02516 | 0.642 |
MOD_N-GLC_1 | 85 | 90 | PF02516 | 0.497 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.648 |
MOD_NEK2_1 | 106 | 111 | PF00069 | 0.541 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.455 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.701 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.720 |
MOD_PIKK_1 | 128 | 134 | PF00454 | 0.599 |
MOD_PIKK_1 | 293 | 299 | PF00454 | 0.558 |
MOD_PKA_2 | 128 | 134 | PF00069 | 0.544 |
MOD_Plk_1 | 1 | 7 | PF00069 | 0.697 |
MOD_Plk_1 | 241 | 247 | PF00069 | 0.626 |
MOD_Plk_1 | 273 | 279 | PF00069 | 0.626 |
MOD_Plk_2-3 | 59 | 65 | PF00069 | 0.600 |
MOD_Plk_4 | 182 | 188 | PF00069 | 0.702 |
MOD_Plk_4 | 273 | 279 | PF00069 | 0.637 |
MOD_Plk_4 | 98 | 104 | PF00069 | 0.612 |
MOD_ProDKin_1 | 110 | 116 | PF00069 | 0.576 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.572 |
MOD_ProDKin_1 | 263 | 269 | PF00069 | 0.644 |
MOD_SUMO_for_1 | 118 | 121 | PF00179 | 0.617 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 183 | 186 | PF00928 | 0.733 |
TRG_ENDOCYTIC_2 | 265 | 268 | PF00928 | 0.731 |
TRG_ENDOCYTIC_2 | 92 | 95 | PF00928 | 0.474 |
TRG_ER_diArg_1 | 128 | 130 | PF00400 | 0.553 |
TRG_ER_diArg_1 | 135 | 138 | PF00400 | 0.585 |
TRG_ER_diArg_1 | 211 | 214 | PF00400 | 0.588 |
TRG_ER_diArg_1 | 257 | 260 | PF00400 | 0.690 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.581 |
TRG_NLS_MonoCore_2 | 283 | 288 | PF00514 | 0.559 |
TRG_NLS_MonoExtN_4 | 281 | 288 | PF00514 | 0.557 |
TRG_Pf-PMV_PEXEL_1 | 138 | 142 | PF00026 | 0.648 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILE7 | Leptomonas seymouri | 70% | 98% |
A0A0S4J5W3 | Bodo saltans | 33% | 100% |
A0A1X0NK79 | Trypanosomatidae | 45% | 81% |
A0A3R7NJS2 | Trypanosoma rangeli | 53% | 89% |
A0A3S5H5P1 | Leishmania donovani | 95% | 100% |
A4H4J3 | Leishmania braziliensis | 88% | 100% |
A4HSR8 | Leishmania infantum | 95% | 100% |
C9ZTC1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 85% |
Q4QJ52 | Leishmania major | 95% | 100% |
V5AQD0 | Trypanosoma cruzi | 52% | 90% |